Envisagenics Funding & Investors
New York, NY
Envisagenics, Inc. develops health care software. The Company offers an artificial intelligence platform for drug discovery. Envisagenics provides RNA splicing analytics and artificial intelligence for therapeutic solutions. Envisagenics serves customers in the State of New York.
envisagenics.comTotal Amount Raised: $52,056,624
Envisagenics Funding Rounds
Series B
$25,000,000
Series B Investors
Red Cell PartnersBristol-Myers Squibb CompanyEmpire State DevelopmentThird Kind Venture CapitalGrant
$2,000,000
Grant Investors
National Cancer Institute (NCI)Series A
$19,181,626
Series A Investors
Red Cell PartnersDynamk CapitalThird Kind Venture CapitalMadronaNew York VenturesM12Grant
$300,000
Grant Investors
National Cancer Institute (NCI)Grant
$1,500,000
Grant Investors
National Institutes of Health (NIH)Seed
$1,000,000
Seed Investors
M12MadronaSeed
$2,400,000
Seed Investors
Dynamk CapitalSV AngelState of New YorkDolby Family VenturesThird Kind Venture CapitalCosineGrant
$350,000
Grant Investors
The Thiel FoundationGrant
$225,000
Grant Investors
National Institutes of Health (NIH)Pre Seed
$50,000
Pre Seed Investors
the Long Island Emerging technologies Fund (LIETF)Grant
$50,000
Grant Investors
Accelerate Long Island
Funding info provided by Diffbot.